Literature DB >> 17566110

The properties of a mammary gland cancer stem cell.

I Zucchi1, S Sanzone, S Astigiano, P Pelucchi, M Scotti, V Valsecchi, O Barbieri, G Bertoli, A Albertini, R A Reinbold, R Dulbecco.   

Abstract

The cancer stem cell hypothesis posits that tumors are derived from a single cancer-initiating cell with stem cell properties. The task of identifying and characterizing a single cancer-initiating cell with stem cell properties has proven technically difficult because of the scarcity of the cancer stem cells in the tissue of origin and the lack of specific markers for cancer stem cells. Here we show that a single LA7 cell derived from rat mammary adenocarcinoma has the following properties: the differentiation potential to generate all of the cell lineages of the mammary gland; the ability to generate branched duct-like structures that recapitulate morphologically and functionally the ductal-alveolar-like architecture of the mammary tree; and the capacity to initiate heterogeneous tumors in nonobese diabetic-SCID mice. In addition, we show that cultured cells derived from tumors generated by a single LA7 cell-injection have properties similar to LA7 cells, can generate all of the cell lineages of the mammary gland, and recapitulate the ductal-alveolar-like architecture of the mammary tree. The properties of self-renewal, extensive capacity for proliferation, multilineage differentiation potential, and single-cell tumor-initiation potential suggest that LA7 cells are cancer stem cells and can be used as a model system to study the dynamics of tumor formation at the single-cell level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566110      PMCID: PMC1965538          DOI: 10.1073/pnas.0703071104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Dome formation in cell cultures as expression of an early stage of lactogenic differentiation of the mammary gland.

Authors:  I Zucchi; L Bini; D Albani; R Valaperta; S Liberatori; R Raggiaschi; C Montagna; L Susani; O Barbieri; V Pallini; P Vezzoni; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

2.  Generation of a functional mammary gland from a single stem cell.

Authors:  Mark Shackleton; François Vaillant; Kaylene J Simpson; John Stingl; Gordon K Smyth; Marie-Liesse Asselin-Labat; Li Wu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  Genetic dissection of dome formation in a mammary cell line: identification of two genes with opposing action.

Authors:  I Zucchi; C Montagna; L Susani; R Montesano; M Affer; S Zanotti; E Redolfi; P Vezzoni; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Hematopoietic stem cell quiescence maintained by p21cip1/waf1.

Authors:  T Cheng; N Rodrigues; H Shen; Y Yang; D Dombkowski; M Sykes; D T Scadden
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

6.  Proteomic dissection of dome formation in a mammary cell line: role of tropomyosin-5b and maspin.

Authors:  I Zucchi; L Bini; R Valaperta; A Ginestra; D Albani; L Susani; J C Sanchez; S Liberatori; B Magi; R Raggiaschi; D F Hochstrasser; V Pallini; P Vezzoni; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

7.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

8.  Identification and expansion of human colon-cancer-initiating cells.

Authors:  Lucia Ricci-Vitiani; Dario G Lombardi; Emanuela Pilozzi; Mauro Biffoni; Matilde Todaro; Cesare Peschle; Ruggero De Maria
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

9.  Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast.

Authors:  J Stingl; C J Eaves; U Kuusk; J T Emerman
Journal:  Differentiation       Date:  1998-08       Impact factor: 3.880

10.  The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells.

Authors:  M Simian; Y Hirai; M Navre; Z Werb; A Lochter; M J Bissell
Journal:  Development       Date:  2001-08       Impact factor: 6.868

View more
  34 in total

Review 1.  Cancer stem cells in multiple myeloma.

Authors:  Nilanjan Ghosh; William Matsui
Journal:  Cancer Lett       Date:  2008-09-21       Impact factor: 8.679

Review 2.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 3.  Development and maintenance of cancer stem cells under chronic inflammation.

Authors:  Toshihiko Tanno; William Matsui
Journal:  J Nippon Med Sch       Date:  2011       Impact factor: 0.920

4.  O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1.

Authors:  Huabei Guo; Bing Zhang; Alison V Nairn; Tamas Nagy; Kelley W Moremen; Phillip Buckhaults; Michael Pierce
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

5.  Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.

Authors:  Huabei Guo; Tamas Nagy; Michael Pierce
Journal:  J Biol Chem       Date:  2014-10-01       Impact factor: 5.157

6.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.

Authors:  Ming Luo; Huaping Fan; Tamas Nagy; Huijun Wei; Chenran Wang; Suling Liu; Max S Wicha; Jun-Lin Guan
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.

Authors:  Gérald J Prud'homme; Yelena Glinka; Anna Toulina; Olga Ace; Venkateswaran Subramaniam; Serge Jothy
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

8.  Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

Authors:  Julio E Celis; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans-Wielenga; Fritz Rank; José M A Moreira
Journal:  Mol Oncol       Date:  2007-09-25       Impact factor: 6.603

Review 9.  Normal stem cells in cancer prone epithelial tissues.

Authors:  T J Phesse; A R Clarke
Journal:  Br J Cancer       Date:  2009-01-06       Impact factor: 7.640

10.  BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.

Authors:  Julian Puppe; Rinske Drost; Xiaoling Liu; Simon A Joosse; Bastiaan Evers; Paulien Cornelissen-Steijger; Petra Nederlof; Qiang Yu; Jos Jonkers; Maarten van Lohuizen; Alexandra M Pietersen
Journal:  Breast Cancer Res       Date:  2009-08-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.